How It Is Given
Getting Started
Most Common
Side effects
Breast tenderness, mild bloating, occasional nausea and irregular spotting are all common in the first weeks and most settle by month three. A smaller set of symptoms means something is wrong and should prompt a call rather than patience. How we weigh it with Austin patients.
Common and settling
Breast tenderness in the first weeks is expected, not a sign that something is wrong, and a Austin patient who knows that is less likely to stop early. Breast tenderness is the most frequently reported early effect, and it usually eases within six to eight weeks as your body adjusts to a steadier estrogen level.
Irregular spotting is common in the first three to six months of continuous combined therapy while the uterine lining settles into a new pattern. It is not a sign the treatment is failing.
Mild bloating, slight fluid retention, headaches in the first weeks and mild nausea with oral preparations all appear and generally resolve. Taking an oral dose with food helps with the last one. Worth reading next: safety and risks, what to expect first and common questions. Small adjustments solve most of these: taking the tablet with food for nausea, or moving to a patch if oral preparations do not suit a Austin patient.
Managing them
Most early effects settle by the third month. Stopping at week three means never finding out whether it would have worked.
If an effect persists, we adjust the dose or the form, not both. Otherwise you learn nothing from the result.
Nausea usually belongs to oral preparations. Skin irritation usually belongs to patches. Switching route often solves either.
Persistent effects past three months are worth a conversation rather than tolerating indefinitely.
When to call
A handful of symptoms sit outside the settling-in category entirely, and any of them means a same-day call to your Austin clinician rather than a wait. Call the same day for calf pain or swelling, chest pain, sudden breathlessness, sudden severe headache, or visual disturbance. Those need assessing for clot or stroke rather than attributing to treatment.
Heavy bleeding, bleeding that starts after a settled period without it, or any bleeding more than six months into continuous therapy should be reported. It usually turns out to be benign and it needs checking rather than assuming. There is more in blood clot and stroke risk, who should not take hrt and joint and muscle pain for the rest of it. Unexpected bleeding is worth reporting even when you are fairly certain it is nothing, because in Austin as anywhere the reassurance comes from the check.
More on safety
Six concerns, each taken one at a time, with the actual numbers.
What goes up, what goes down and by how much.
Learn moreCombined therapy versus estrogen alone.
Learn moreWhy the route into your body changes this one.
Learn moreThe contraindications, stated plainly.
Learn moreCommon questions
What is normal, how long it lasts, and when to pick up the phone.
Patient reviews
I had been waking three or four times a night for two years and had been told it was just stress. The consultation actually went through my cycle history. Six weeks on a patch and I am sleeping through.
What I wanted was someone who would talk about the risks honestly rather than sell me something. They walked through the clot data and why a patch suited me better than tablets.
The brain fog was the part nobody warned me about. Having a clinician tell me it was a recognized symptom and not early dementia was worth the appointment on its own.
It took two dose changes before things settled, which they had told me upfront might happen. The three-month review was booked before I left the first appointment.
From the blog
Next step
Most women who stop in the first month stop because nobody told them what to expect. Twenty minutes of expectation-setting prevents it.
Consultations are by appointment. Prescriptions are issued only where clinically appropriate.